These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Urban NB; Slifstein M; Thompson JL; Xu X; Girgis RR; Raheja S; Haney M; Abi-Dargham A Biol Psychiatry; 2012 Apr; 71(8):677-83. PubMed ID: 22290115 [TBL] [Abstract][Full Text] [Related]
29. The relationship between the striatal dopamine transporter and novelty seeking and cognitive flexibility in opioid dependence. Liang CS; Ho PS; Yen CH; Chen CY; Kuo SC; Huang CC; Yeh YW; Ma KH; Huang SY Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():36-42. PubMed ID: 27940252 [TBL] [Abstract][Full Text] [Related]
30. Oxytocin enhances attractiveness of unfamiliar female faces independent of the dopamine reward system. Striepens N; Matusch A; Kendrick KM; Mihov Y; Elmenhorst D; Becker B; Lang M; Coenen HH; Maier W; Hurlemann R; Bauer A Psychoneuroendocrinology; 2014 Jan; 39():74-87. PubMed ID: 24275006 [TBL] [Abstract][Full Text] [Related]
31. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography. Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314 [TBL] [Abstract][Full Text] [Related]
32. Striatal dopaminergic reward response relates to age of first drunkenness and feedback response in at-risk youth. Weiland BJ; Zucker RA; Zubieta JK; Heitzeg MM Addict Biol; 2017 Mar; 22(2):502-512. PubMed ID: 26732626 [TBL] [Abstract][Full Text] [Related]
33. The polymorphism of dopamine D2 receptor TaqIA gene is associated with brain response to drug cues in male heroin-dependent individuals during methadone maintenance treatment. Li Y; Li Q; Li W; Chen J; Hu F; Liu Y; Wei X; Zhu J; Liu J; Ye J; Shi H; Wang Y; Wang W Drug Alcohol Depend; 2019 May; 198():150-157. PubMed ID: 30928885 [TBL] [Abstract][Full Text] [Related]
34. Increased binding potential of [(11)C]raclopride during unilateral continuous microinjection of nicotine in rat striatum observed by positron emission tomography. Tajima T; Hatano K; Suzuki M; Ogawa M; Sakiyama Y; Kato T; Endo H; Miura H; Matsubara M; Ito K Synapse; 2007 Dec; 61(12):943-50. PubMed ID: 17787002 [TBL] [Abstract][Full Text] [Related]
35. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. Volkow ND; Wang GJ; Telang F; Fowler JS; Logan J; Jayne M; Ma Y; Pradhan K; Wong C J Neurosci; 2007 Nov; 27(46):12700-6. PubMed ID: 18003850 [TBL] [Abstract][Full Text] [Related]
36. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis. Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030 [TBL] [Abstract][Full Text] [Related]
37. Novel circuit biomarker of impulsivity and craving in male heroin-dependent individuals. Yang W; Wang S; Shao Z; Yang R; Tang F; Luo J; Yan C; Zhang J; Chen J; Liu J; Yuan K Drug Alcohol Depend; 2021 Feb; 219():108485. PubMed ID: 33360853 [TBL] [Abstract][Full Text] [Related]
38. Reward motivation in humans and its relationship to dopamine D Caravaggio F; Fervaha G; Browne CJ; Gerretsen P; Remington G; Graff-Guerrero A J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593 [TBL] [Abstract][Full Text] [Related]
39. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Barrett SP; Boileau I; Okker J; Pihl RO; Dagher A Synapse; 2004 Nov; 54(2):65-71. PubMed ID: 15352131 [TBL] [Abstract][Full Text] [Related]
40. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). Potter JS; Marino EN; Hillhouse MP; Nielsen S; Wiest K; Canamar CP; Martin JA; Ang A; Baker R; Saxon AJ; Ling W J Stud Alcohol Drugs; 2013 Jul; 74(4):605-13. PubMed ID: 23739025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]